Latest Malaysia News

Perseus Mining reported a 5% revenue increase to US$608.5 million for the half-year ended December 2025, despite an 8% drop in net profit and a 26% decline in gold production. The company declared a steady interim dividend and outlined ongoing operational challenges and corporate restructuring.

Macmahon Holdings has reported a robust first half of FY26, delivering double-digit growth in revenue and earnings alongside a significant dividend increase and reaffirmed full-year guidance.

Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.

Ovanti Limited has completed a $1.08 million capital raise through a large share placement aimed at funding its growing U.S. buy now, pay later business and global operations.

Cochlear Limited reported a modest 1% rise in sales but a 9% fall in underlying net profit for the half year ended December 2025, as the rollout of its innovative Nucleus Nexa System faced longer-than-expected regulatory and contract hurdles. The company anticipates a robust second half driven by broader product availability and service growth.

Xamble Group Limited is set to acquire a majority stake in YouthsToday, significantly broadening its influencer marketing platform across Southeast Asia and boosting its creator base and agency partnerships.

Enova Mining has reported significant near-surface titanium, rare earth, and niobium mineralisation at its CODA projects in Brazil, alongside ongoing diamond drilling at East Salinas targeting high-grade rare earth zones.

Activeport Group Ltd reported steady Q2 FY26 revenue with new contracts starting to contribute and a 5% increase in annualised recurring revenue to $6.3 million. The company also reduced cash burn significantly and strengthened its cash position to support growth.

Hydrocarbon Dynamics Limited has entered voluntary suspension pending a major transaction announcement while continuing global trials of its Multi-Flow product. A new auditor appointment and board leadership change mark a period of strategic transition.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

Latrobe Magnesium has resolved a critical manufacturing defect at its Demonstration Plant, enabling Magnesium Oxide production to resume, while securing key financial support for its commercial expansion plans.

Osteopore Limited reported a 30% year-on-year revenue increase in Q4 CY25, overcoming a slowdown in South Korea, and secured a strategic five-year partnership with DKSH Malaysia to expand its dental product reach.